Polyethylene Glycol Diacrylate (PEGDA) Hydrogels

Polyethylene glycol diacrylate, commonly abbreviated PEGDA, is a light-curable synthetic polymer that forms hydrogels when exposed to ultraviolet or visible light in the presence of a photoinitiator. It has become one of the most widely used building blocks in biomedical materials research because of its water-absorbing capacity, tunable mechanical properties, and low toxicity to cells. From 3D-printed tissue scaffolds to antifouling coatings and pH-responsive micro-robots, PEGDA shows up in a remarkable range of applications, each exploiting a slightly different facet of its chemistry.

How Light Turns PEGDA Into a Gel

PEGDA is essentially a chain of polyethylene glycol capped on both ends with acrylate groups. Those acrylate groups are the reactive handles: when you shine light on a mixture of PEGDA and a photoinitiator, the initiator generates free radicals that cause the acrylate ends to link together. As neighboring chains cross-link, the liquid rapidly solidifies into a water-swollen network, a hydrogel. The speed and completeness of this reaction depend on the initiating system, the light intensity, and the curing time.

A standard two-component initiating system can push the conversion of reactive double bonds to roughly half in a minute under low-power green light. More advanced three-component systems push that conversion past 90 percent in the same time frame, dramatically improving how fully the gel cross-links.¹ In contact-lens formulations, researchers have reported double-bond conversion rates ranging from about 45 to 75 percent depending on composition, with conversion climbing steeply in the first few minutes of curing and then plateauing.² The practical takeaway is that the degree of cure is highly adjustable, and that adjustability feeds directly into how stiff, how porous, and how durable the final gel will be.

Picking the Right Photoinitiator

The photoinitiator you pair with PEGDA matters enormously, especially when living cells are involved. Two of the most common choices in biomedical work are Irgacure 2959 (often written I2959) and lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP). LAP absorbs light efficiently at 365 nm, which means it can cure PEGDA faster at lower concentrations. In one study, human fibroblasts encapsulated in PEGDA gels cured with LAP showed survival rates above 95 percent after 24 hours, matching the survival seen with a much longer I2959 cure, while needing far less initiator and a fraction of the light exposure time.³

The picture is not entirely one-sided, though. When the goal is maximum gel stiffness rather than speed, I2959 may have an edge. A comparative evaluation of both initiators across multiple hydrogel platforms found that the peak storage modulus achieved with I2959 in PEGDA gels was roughly 8 percent higher than with LAP, suggesting that I2959 produces a slightly denser cross-linked network under certain conditions.⁴ In practice, most labs choose LAP when they need fast, cell-friendly curing and switch to I2959 when mechanical performance is the priority.

Controlling Stiffness and Swelling

One of PEGDA’s strongest selling points is tunability. You can make gels that feel almost liquid-soft or gels stiff enough to mimic cartilage, and the main lever is the molecular weight of the PEG chain between those two acrylate end caps. A short chain means the cross-links are packed close together, producing a dense, rigid, slowly swelling gel. A long chain spaces the cross-links farther apart, yielding a softer, more water-absorbent network.⁵ Raising the overall PEGDA concentration in the precursor solution has a similar tightening effect.⁶

These relationships let researchers create substrates with spatially patterned stiffness using photolithographic techniques, placing a stiff region right next to a soft region on the same gel to study how cells respond to mechanical gradients.⁷ That kind of control is difficult to achieve with most natural polymers, which is a big reason PEGDA keeps showing up in mechanobiology research.

Teaching PEGDA to Talk to Cells

Pure PEGDA gels are biologically inert. Cells cannot grab onto them, which is both a feature and a limitation. It is a feature when you want to prevent unwanted cell attachment, for instance in a protective coating around transplanted tissue. It is a limitation when you are building a scaffold where cells need to adhere, spread, and proliferate. The standard workaround is to tether short adhesion peptides, most commonly the amino acid sequence RGD, directly onto the PEGDA backbone.

Incorporating RGD peptides into PEGDA hydrogels at varying concentrations has been shown to promote the attachment and bone-forming activity of marrow stromal cells in three-dimensional culture, and the response scales with the dose of peptide incorporated.⁸ Cyclic versions of RGD peptides perform even better for certain cell types: hydrogels modified with cyclic RGD supported significantly more endothelial cell attachment and spreading than gels modified with the linear version, even at lower peptide concentrations.⁹ The ability to dial in exactly how sticky or non-sticky the surface is gives PEGDA an unusual level of biological programmability for a synthetic material.

Cell Encapsulation and 3D Bioprinting

Wrapping living cells inside PEGDA microspheres or printed structures is a major application area, and here the molecular weight choice becomes especially consequential. Higher molecular weight PEGDA produces a looser network with larger pores, which allows nutrients and oxygen to diffuse in more freely. Studies have consistently found that cells survive better in higher molecular weight PEGDA microspheres.¹⁰ On the other hand, oxygen itself can interfere with the polymerization process at the microscale, inhibiting the chain-growth reaction and paradoxically lowering cell survival during the curing step.¹¹ Balancing these competing effects is one of the trickier aspects of working with PEGDA at small scales.

In 3D bioprinting, PEGDA serves as a photocurable bioink that solidifies layer by layer under light. Because pure PEGDA does not let cells adhere, researchers typically blend it with biological components. One approach combines PEGDA with self-assembling peptide nanofibers to print hollow, lumen-like structures that cells can populate, creating rudimentary tubular tissues.¹² For transplantation applications such as islet encapsulation for diabetes, researchers have designed layered architectures where a non-adhesive PEGDA shell protects the cells from immune attack while a second, biologically active hydrogel layer on the outside promotes blood-vessel growth to keep the encapsulated tissue nourished.¹³

Drug Delivery and Controlled Release

PEGDA hydrogels can act as reservoirs that release a drug payload gradually. The release rate depends on the mesh size of the gel network and the size of the drug molecule. In semi-interpenetrating networks made from PEGDA and gelatin, increasing the PEGDA content slowed down the initial burst of drug release and reduced the rate at which molecules diffused through the gel, giving researchers a straightforward knob for tuning how quickly a therapeutic agent reaches its target.¹⁴ Larger drug molecules, predictably, move through the gel more slowly than smaller ones, so the same PEGDA formulation can deliver a small-molecule drug quickly and a protein drug slowly.

How PEGDA Degrades Over Time

PEGDA is sometimes described as non-degradable, and for short-term lab experiments that description is close enough. But in living tissue, PEGDA hydrogels do break down. The weak link is the ester bond that forms where each acrylate group joins the PEG chain. Water slowly cleaves those ester bonds through hydrolysis, and that process accelerates in the warm, enzyme-rich environment inside the body.¹⁵

A rat implantation study confirmed that the primary breakdown mechanism in vivo is ester hydrolysis, not oxidation: PEGDA gels showed significant swelling and softening over 12 weeks under the skin, while a chemically similar polymer without the ester linkage (PEGDAA) remained stable over the same period.¹⁶ When PEGDA is formulated as nanoparticles rather than bulk gels, degradation happens much faster because of the higher surface-area-to-volume ratio. By adjusting the proportion of PEGDA and adding co-monomers, researchers can tune nanoparticle degradation from hours to weeks.¹⁷ This tunability matters: an implant meant to stay put for months needs slow degradation, while a drug-delivery nanoparticle that should empty its payload in days needs fast degradation.

The Immune Response to Implanted PEGDA

No implanted material escapes the body’s immune surveillance entirely, and PEGDA is no exception. When PEGDA hydrogels are placed under the skin, the body mounts what is known as a foreign body response: inflammatory cells accumulate at the surface, and over weeks, a fibrous capsule forms around the implant. In a 28-day mouse study, all tested PEG-based hydrogels developed a thick inflammatory cell layer and a surrounding fibrous capsule, though gels modified with RGD peptides developed a thinner and less dense capsule than unmodified gels.¹⁸

Recent work has started to unpack the molecular triggers behind this response. Proteins from blood plasma adsorb onto the PEGDA surface and are altered in the process, generating damage-associated molecular patterns that activate specific toll-like receptors on immune cells. Knocking out these receptors in mice reduced both the inflammatory cell layer and the fibrous capsule by roughly half, pointing toward potential strategies for engineering less inflammatory PEGDA formulations.¹⁹ It is worth noting that in a head-to-head comparison with other polymers used for neural implant coatings, PEGDA showed relatively strong foreign body reaction including fibrosis and formation of multinucleated giant cells, suggesting that its biocompatibility profile is favorable for some uses but not universally gentle.²⁰

Blending PEGDA With Natural Polymers

Pure PEGDA gives you precise mechanics but no biological cues. Natural polymers like gelatin give you built-in cell-binding sites but tend to be mechanically weak and degrade unpredictably. Combining the two into interpenetrating or hybrid networks is a well-established strategy to get the best of both worlds.

PEGDA-gelatin hybrids cross-linked by electron beam irradiation showed a storage modulus over ten times higher than pure gelatin hydrogels at the same irradiation dose, without introducing any cytotoxicity.²¹ Thiolated gelatin blended with PEGDA into interpenetrating networks offered similar flexibility, with properties tunable primarily by adjusting the ratio of the two components rather than the initiator concentration, and none of the formulations showed toxicity to fibroblasts or skin cells.²² Older work on modified gelatin and PEGDA interpenetrating networks likewise found enhanced elasticity and strength compared to gelatin cross-linked the traditional way with glutaraldehyde.²³ The consistent thread across these studies is that even modest additions of PEGDA can dramatically reinforce a soft biological gel without poisoning the cells living inside it.

Antifouling Coatings

PEGDA’s resistance to protein adsorption makes it useful for surface coatings on membranes and medical devices. When PEGDA hydrogel layers are grafted onto filtration membranes, the coated surfaces adsorb less protein than bare membranes regardless of the protein’s charge, reducing fouling from negatively charged, neutral, and positively charged proteins alike.²⁴ PEGDA-modified surfaces have also demonstrated strong antifouling performance against specific test proteins compared to conventional bovine serum albumin coatings in reflectometric interference testing.²⁵

That said, PEGDA is not the ultimate antifouling material. Zwitterionic hydrogels built from poly(carboxybetaine diacrylate) cross-linkers reduced protein adsorption by more than 60 percent compared to PEGDA-based gels, while matching PEGDA’s ability to resist bacterial adhesion.²⁶ PEGDA remains a practical choice because it is inexpensive, easy to cure, and well characterized, but researchers working on long-duration implants or marine coatings are increasingly exploring alternatives with even stronger fouling resistance.

Soft Robots and Responsive Actuators

PEGDA is finding a second life in the emerging field of soft robotics, where its ability to swell and contract in response to environmental changes can be turned into mechanical motion. One design embeds iron oxide particles in a PEGDA layer and pairs it with a pH-responsive hydrogel in a bilayer structure. The PEGDA layer acts as both a structural backbone and a magnetic handle, letting an external magnetic field steer the micro-robot through fluid, while the pH-sensitive partner layer swells or contracts to grip and release a drug cargo when it reaches a target environment.²⁷

A more recent actuator takes this further by using the body’s own chemistry as the control signal. A bilayer of bovine serum albumin-PEGDA paired with a passive PEGDA layer swells rapidly in acidic stomach fluid and then softens as digestive enzymes break down the protein component, driving reversible shape changes that could trigger timed drug release entirely without external electronics or manual intervention.²⁸ These designs illustrate how PEGDA’s role is evolving from a passive scaffold material into an active component in programmable medical devices, leveraging the same tunability that made it popular in tissue engineering but directing it toward mechanical rather than purely structural goals.

1
Journal of Photochemistry and Photobiology A: Chemistry. An initiating system with high efficiency for PEGDA photopolymerization at 532 nm ↩︎
2
PubMed Central. Polyethylene Glycol Diacrylate Adapted Photopolymerization Material for Contact Lens with Improved Elastic Modulus Properties ↩︎
3
PubMed Central. Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility ↩︎
4
Biomacromolecules. Evaluating Cross-Linking Efficiency and Cytocompatibility of Three Commonly Used Photoinitiators across Different Cell-Compatible Hydrogel Platforms ↩︎
5
PubMed Central. Promoting Nerve Cell Functions on Hydrogels Grafted with Poly(L-lysine) ↩︎
6
PubMed Central. Bioprinting of GelMA/PEGDA Hybrid Bioinks for SH-SY5Y Cell Encapsulation: Role of Molecular Weight and Concentration ↩︎
7
PubMed. PEGDA hydrogels with patterned elasticity: Novel tools for the study of cell response to substrate rigidity ↩︎
8
PubMed. The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells ↩︎
9
PubMed Central. Design and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptides ↩︎
10
PubMed. The effect of polymer molecular weight and cell seeding density on viability of cells entrapped within PEGDA hydrogel microspheres ↩︎
11
PubMed Central. A microfluidic-based cell encapsulation platform to achieve high long-term cell viability in photopolymerized PEGNB hydrogel microspheres ↩︎
12
PubMed Central. Bioprinting 3D lattice-structured lumens using polyethylene glycol diacrylate (PEGDA) combined with self-assembling peptide nanofibers as hybrid bioinks for anchorage dependent cells ↩︎
13
PubMed Central. Layered PEGDA hydrogel for islet of Langerhans encapsulation and improvement of vascularization ↩︎
14
PubMed Central. Drug release kinetics and transport mechanisms from semi-interpenetrating networks of gelatin and poly(ethylene glycol) diacrylate ↩︎
15
PubMed. Development of a biostable replacement for PEGDA hydrogels ↩︎
16
PubMed Central. Determination of the in vivo degradation mechanism of PEGDA hydrogels ↩︎
17
PubMed Central. Degradation Profiles of Poly(ethylene glycol) diacrylate (PEGDA)-based hydrogel nanoparticles ↩︎
18
PubMed Central. Linking the foreign body response and protein adsorption to PEG-based hydrogels using proteomics ↩︎
19
PubMed Central. Damage Associated Molecular Patterns (DAMPs) Mediate the Foreign Body Response to Poly(ethylene glycol) Diacrylate Hydrogels via Toll like Receptors ↩︎
20
PubMed Central. Foreign Body Reaction to Neural Implants: A Comparative Study of Polymer Toxicity and Tissue Response ↩︎
21
PubMed Central. A study on the material properties of novel PEGDA/gelatin hybrid hydrogels polymerized by electron beam irradiation ↩︎
22
PubMed Central. Fabrication Parameter-Dependent Physico-Chemical Properties of Thiolated Gelatin/PEGDA Interpenetrating Network Hydrogels ↩︎
23
PubMed. Synthesis and physicochemical analysis of interpenetrating networks containing modified gelatin and poly(ethylene glycol) diacrylate ↩︎
24
Colloids and Surfaces A: Physicochemical and Engineering Aspects. Anti-biofouling membranes via hydrogel electron beam modification – A fundamental and applied study ↩︎
25
Advanced Materials Interfaces. Antifouling PEG Coatings by Thiol‐Acrylate Conjugate Addition Reactions for Generation of Protein Patterns via Photobleaching‐Induced Protein Binding (PiPB) BioBitmaps Using Maskless Projection Lithography ↩︎
26
PubMed. Antifouling Hydrogel Based on Zwitterionic Poly(carboxybetaine diacrylate) Cross-Linkers ↩︎
27
Smart Materials and Structures. Magnetic actuated pH-responsive hydrogel-based soft micro-robot for targeted drug delivery ↩︎
28
PubMed Central. Autonomous Hydrogel Actuators Programmed by Endogenous Biochemical Logic for Dual-Stage Morphing and Drug Release ↩︎